scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.12.8.879 |
P953 | full work available at URL | https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.12.8.879 |
P698 | PubMed publication ID | 1637785 |
P2093 | author name string | P. K. Siegl | |
C. T. Dunwiddie | |||
J. T. Davidson | |||
G. P. Vlasuk | |||
L. W. Schaffer | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thrombosis | Q261327 |
Cardiology and cardiovascular medicine | Q96320350 | ||
direct Xa inhibitor | Q906280 | ||
P304 | page(s) | 879-885 | |
P577 | publication date | 1992-08-01 | |
P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
P1476 | title | Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons | |
P478 | volume | 12 |
Q35672783 | A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates |
Q77153138 | Antithrombotic effect of YM-75466 is separated from its effect on bleeding time and coagulation time |
Q41972518 | Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time |
Q74014924 | Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis |
Q74551385 | Blood flow and antithrombotic drug effects |
Q28190575 | Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy |
Q40463597 | Novel Antithrombotic Drugs in Development |
Q40725160 | Novel antithrombotic therapy. |
Q34027530 | Novel inhibitors of factor X for use in cardiovascular diseases |
Q53772864 | Preincubation of Dacron grafts with recombinant tissue factor pathway inhibitor decreases their thrombogenicity in vivo. |
Q43911200 | The discovery of YM-60828: a potent, selective and orally-bioavailable factor Xa inhibitor |
Q57310720 | YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time |
Search more.